Treatments for hepatitis C, hemophilia, and cholesterol among specialty drugs approved for new indications this year.
The process of bringing a drug to market is expensive and can take several years. In response, the industry has taken to recycling failed and existing medications for novel indications.
As specialty drugs continue to leave a mark on the health care space, take a look at specialty medications previously approved by the FDA that received new indications in 2017, thus far.
Graphic by Gwen Salas